Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.
Press releases published on June 3, 2025
Global Hemp Fiber Market Set For 36.4% Growth, Reaching $71.96 Billion By 2029
EIN Presswire
·
June 3, 2025
The Business Research Company’s Hemp Fiber Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 3, 2025 /EINPresswire.com/ -- The hemp fiber market has seen unprecedented growth in recent …
Industrial Dispensing System And Equipment Market Forecast 2025-2034: Comprehensive Insights On Market Size, Growth
EIN Presswire
·
June 3, 2025
The Business Research Company’s Industrial Dispensing System And Equipment Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 3, 2025 /EINPresswire.com/ -- The industrial dispensing …
The Medical Affairs Professional Society announces Robin Winter-Sperry, MD, as new President for the Americas Region.
EIN Presswire
·
June 3, 2025
Since joining MAPS in 2018, Dr. Winter-Sperry has demonstrated remarkable dedication and leadership in the organization. GOLDEN, CO, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- The Medical Affairs Professional Society (MAPS), a distinguished non- …
Pharmacomechanical Thrombectomy Market estimated to reach US$ 2.461 billion by 2030 at a CAGR of 7.24%
EIN Presswire
·
June 3, 2025
The pharmacomechanical thrombectomy market is anticipated to grow at a CAGR of 7.24% from US$1.735 billion in 2025 to US$2.461 billion by 2030. NEW YORK, NY, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- According to a new study published by …
Pharmaceutical Visual Inspection Systems Market Size, Share & Forecast 2025-2033 | DataM Intelligence
EIN Presswire
·
June 3, 2025
Growing pharmaceutical production and stricter quality standards propel the visual inspection systems market, integrating AI and automation for optimal results. AUSTIN, TX, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- The pharmaceutical visual …
Cell Surface Markers Detection Market to Hit US$ 10.7 Bn by 2033, Driven by Precision Medicine | DataM Intelligence
EIN Presswire
·
June 3, 2025
Cell surface marker detection is transforming diagnostics with tech breakthroughs and growing use in cancer, autoimmune, and stem cell research. AUSTIN, TX, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- Cell surface markers detection market reached …
Teva Announces Pricing and Early Acceptance Results of its Debt Tender Offer
GlobeNewswire
·
June 3, 2025
TEL AVIV, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today the pricing and early acceptance results of its previously announced tender offers (the “Offers”) to purchase for cash …
Taysha Gene Therapies Announces Details for Oral Presentations at the 2025 IRSF Rett Syndrome Scientific Meeting Reviewing Recent Updates from the TSHA-102 Clinical Program
GlobeNewswire
·
June 3, 2025
Recently disclosed clinical cohort data from high (1x1015 total vg) and low dose (5.7x1014 total vg) TSHA-102 from REVEAL adolescent/adult and pediatric Phase 1/2 trials Caregiver research regarding gain/regain of developmental milestones supporting …
Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 3, 2025
NOVATO, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today …
Fennec Announces Results of Annual Meeting
GlobeNewswire
·
June 3, 2025
RESEARCH TRIANGLE PARK, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April 25, 2025 were elected as directors of …
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
GlobeNewswire
·
June 3, 2025
NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to two new employees. Effective June 1, 2025, in connection with commencing employment, two …
DBV Technologies publie un amendement à son Document d’enregistrement universel 2024
GlobeNewswire
·
June 3, 2025
Châtillon, France, le 3 juin 2025 DBV Technologies publie un amendement à son Document d’enregistrement universel 2024 DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT), (la « Société »), société biopharmaceutique en …
DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
GlobeNewswire
·
June 3, 2025
Châtillon, France, June 03, 2025 DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company …
Yhdysvaltain lääkeviranomainen FDA hyväksyi kolmannen käyttöaiheen darolutamidille edennyttä eturauhassyöpää sairastavien potilaiden hoidossa
GlobeNewswire
·
June 3, 2025
ORION OYJ LEHDISTÖTIEDOTE 3.6.2025 klo 23.30 Yhdysvaltain lääkeviranomainen FDA hyväksyi kolmannen käyttöaiheen darolutamidille edennyttä eturauhassyöpää sairastavien potilaiden hoidossa Darolutamidi on ensimmäinen ja ainoa androgeenireseptorin …
Outset Medical Appoints Renee Gaeta as Chief Financial Officer
GlobeNewswire
·
June 3, 2025
SAN JOSE, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced the appointment of Renee …
U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer
GlobeNewswire
·
June 3, 2025
ORION CORPORATION PRESS RELEASE 3 JUNE 2025 at 23.30 EEST U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer Darolutamide is the first and only in the U.S. and FDA-approved androgen receptor inhibitor ( …
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 3, 2025
SAN FRANCISCO, June 03, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for …
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 3, 2025
WALTHAM, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …
MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
GlobeNewswire
·
June 3, 2025
ROCKVILLE, MD, June 03, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today …
Virtual Healthcare Market CAGR 21.41 % with Growth USD 27026.61 Million by 2033
EIN Presswire
·
June 3, 2025
Global Virtual Healthcare market size is anticipated to be worth USD 5724.75 M in 2025, projected to reach 27026.61 M by 2033 at a CAGR of 21.41% PUNE, INTERNATIONAL, INDIA, June 3, 2025 /EINPresswire.com/ -- "Virtual Healthcare Market" research …